Patients who may have transportation difficulties, live in rural areas, or simply need a more convenient option to be seen were happy to see a new, reliable way to receive care
Ethics statement The study is considered exempt research by the United States Department of Health and Human Services under 45 CFR 46.104(d)(4) as it involved only the secondary use of data that were de-identified in compliance with the Health Insurance Portability and Accountability Act (HIPAA), specifically, 45 CFR 164.514
Because this study used only de-identified data compliant with the requirements of the Health Insurance Portability and Accountability Act, Institutional Review Board review and approval was not needed
Participants receiving retatrutide experienced substantial weight loss from a mean baseline weight of 245.6 lbs
However, if youve had gallbladder issues before, its something to be aware of
About BPC-157 in research Researchers investigate BPC-157 to study cell migration and survival, extracellular-matrix interactions, and angiogenic signalling in controlled, non-clinical models